{"name":"Five Prime Therapeutics, Inc.","slug":"five-prime-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":13178000,"revenueGrowth":-11.4,"grossMargin":0,"rdSpend":65491000,"netIncome":-84328000,"cash":331650000,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2020"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMizAJBVV95cUxOc2xmSVhHbkU4anRvQjhCdEdUTWdsblRPLWJLYnVOdkdvclMxeUkzd3BxUWhfVFluM1oxdFVyWkxmYzk2dDNFZmNsLWVaQmZwcDBjZURYN0pNbG1xTDVaMlZuaDR6R2k5X1J5cU0zMDZVamVmaXFObDAwZzlFWEc4M1pYRTZ4eEJuUGF3cnRKZ3NTZGdTd3BqV194SWN2SFJhWmFfc0RoMDc2U3BiTVduUW9oaGZlMUZnYXRuMGVNQU5TYWZtelQyWk9veC0yNzFRalJLMzItMVFFeFJaRnpRVXYtd3hKLUpqX3dPS0s2RHB5T1BtOTBwVVBpT21nN1RyZGNYOGY2VE1HeFBVNkpwS2dxekh6MGFUaXhZZVE0d050b2hoM0xJUVpidjJsMlBWMzJ2ZFpwUFNqc3FLUk5ldjFfUWFTbEJOVVZGdQ?oc=5","date":"2026-01-12","type":"pipeline","source":"Business Wire","summary":"Judi Health’s Capital Rx Surpasses Five Million Contracted PBM Lives as America’s Largest Employers, Unions, and Leading Health Systems Evolve Their Health Benefits Strategies - Business Wire","headline":"Judi Health’s Capital Rx Surpasses Five Million Contracted PBM Lives as America’s Largest Employers, Unions, and Leading","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxPZjgyZV9CdUlQTUZlT08tS3QyRzVzNGRLamJzNmdWMnNoN1dJejZwNk1uNUN3QXlUNzlXRlpqZ0dfc1BoQUp4eFNjdzdVMnRDanZmemNyTjV4UmEteWh5ME1NRVA0MXNfRENhWk1UQVp0NUcwaGROQlNGMlJBTFlUS1JvdXFDT2VfbzNwSElmYVdic2h2d2FjbGJ2RmF5RGhRZHhhTnl2NUJSTE12TVZ4Y1gzTjIybks3UmNqREhxek1CVVV4?oc=5","date":"2025-06-30","type":"trial","source":"Reuters","summary":"Amgen says gastric cancer drug meets main goal in late-stage trial - Reuters","headline":"Amgen says gastric cancer drug meets main goal in late-stage trial","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxOeC1fVTVqOURkZnFMR0dqRXVGOHA0TG1ienBsOURrWG8wMExMTGw0VEZ1eDJCekN1YmhBZnV2TDZ3Ni1yNFVRYllHSDJKWGc1RUZjd3Z5dEM5aWttQVBSaHVFUjNhMTd0YWlOTDNsU1pVRW10TEJVVExXeFZpeWlyVml5UlM?oc=5","date":"2025-03-31","type":"pipeline","source":"Drug Channels","summary":"The Top Pharmacy Benefit Managers of 2024: Market Share and Key Industry Developments - Drug Channels","headline":"The Top Pharmacy Benefit Managers of 2024: Market Share and Key Industry Developments","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxOTV9jZmdicmVQS25zR2psdjVFQkhQQlh5YTRBYVpHZWE3dVhnSHNuYnlGRVB6bEpoU1BXZ0ktd29wY1JlNUZUbDVpYUVMNkpWMF9UUlhyRXdZamRJTW5oRFlVc3ZfUlNFS0pqbGVHR3VmUHVTMlNGR0N5c19ZVDRsNk5vTTVIeEc2ejRCd0tEeXRSZUlNR3oxLTExZFFuN3U3Wk4yZHFFTGtXU2lETGJEUVhDamRPMkVw?oc=5","date":"2023-03-27","type":"pipeline","source":"Ohio Attorney General (.gov)","summary":"Yost Sues Express Scripts, Prime Therapeutics and 5 Others, Blaming Exorbitant Drug Prices on Their Collusion - Ohio Attorney General (.gov)","headline":"Yost Sues Express Scripts, Prime Therapeutics and 5 Others, Blaming Exorbitant Drug Prices on Their Collusion - Ohio Att","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8gFBVV95cUxOaTRzNTIzLUpSTndkZ05ma001bmZkWFl0dlliMkxlM0ZBZzYxczk2ZGFDUURSRnd4bkxtTDFSc09KZUNwSXR5a2p0TnJrdkN0RVVuTTZibVlXMnNnX3NQRDRNbVZrVW5YSWhicGFhX3Q5dXRvVVBOa1JBdkdJWTBLMjhiMV9fMEQ0WUtXZzJtM0RULVJVUC1fa09SSUVGN0N0OFdvVElWeG5jM1ZHMXJxYWE3RXY4VVh4T09hZ01KVVBITHdJYmNSdmxWejBXT3pkbzZvNWxqLTc3bGw1X1JpQ3ZxQTZFS3hyM0Y5dGZ5c1YtUQ?oc=5","date":"2021-05-31","type":"deal","source":"PPF Group","summary":"Takeda exercised its option to acquire Maverick Therapeutics and its T cell engagers - PPF Group","headline":"Takeda exercised its option to acquire Maverick Therapeutics and its T cell engagers","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxOU3RuRXExMno0X3JiSHNEdUpjSkpDNG5tLWVySVBpd2JDNmhqcHpTalRGUlpmOFpjMnJ3TEs2NV9Menpsc3NSQWhUMU1vTEFWU0pwYjJDdDdzLWgzZjR5RTVqb1U2WlM1TFVpRFYzXzQxdlFiTm5MTktBeG9jRGRGblV5T3htTHZhY1FUZHRPbFpaUlNPZGdoVGZqYmlDUQ?oc=5","date":"2021-04-16","type":"pipeline","source":"Drug Delivery Business","summary":"Amgen completes $1.9B acquisition of Five Prime Therapeutics - Drug Delivery Business","headline":"Amgen completes $1.9B acquisition of Five Prime Therapeutics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxPNFh4TGY5d2lwN1FYWmtnWERzeW5YOXJHanltUDNpdHNuZVJ0b1AxdFFZOUQyX2pFdHJqOC1XRDdCbllSa0ExczJtUEJLVTVvYkRkcWdXdDlTTFdfN0pWYzJjanNYYldjZmZia2steTc0aGMxMDRpdHl1d3M1STlSaUJGN2xkQWtNUVRualJGTC1abFMwdm40TVFDd0FHM3FHd2NDVWt5YUtKbzJPMVNDUmlUdFIwTXF1QjB1bA?oc=5","date":"2021-03-04","type":"deal","source":"PR Newswire","summary":"Amgen To Acquire Five Prime Therapeutics For $1.9 Billion in Cash - PR Newswire","headline":"Amgen To Acquire Five Prime Therapeutics For $1.9 Billion in Cash","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxOVGJlUGNjWDgyVFR3N04xd2RqcVNrNkFQT2Nsdng3ZHJZRUtqeEp2U1BScFJiQWNkWlI5TTNERThISDBsZFNnbHJ2b1hqWkR6SzZPTVZWR2xMWUx5TUVmazVLbm5pWkNPekN6VUh1dFZqWUplM0c3ZnoxaEF3ejVHcTNlZEU2Z2lHVXdtV1lqUVdhZ0FjMTNOank0aEpWaXhoYmFnamxn?oc=5","date":"2021-03-04","type":"pipeline","source":"Fierce Biotech","summary":"Prime time for Five Prime as Amgen snaps up this once-moribund biotech for $1.9B and its phoenix-from-the-flames cancer asset - Fierce Biotech","headline":"Prime time for Five Prime as Amgen snaps up this once-moribund biotech for $1.9B and its phoenix-from-the-flames cancer ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxORXJIVHpHVzczYTNXUGp2SHFoU0d6aDUtVnpSb3E5VFNudnE2YVVKUEx4WkNpSTlQSkl5RGRjd05mUjB5cm1ycWxjeU9iR2dPLUhMRzZKWDlYdW9iXy1uNjl2bjVLaUh3YVc1RzRDci1meEtmYkg5TTdWT2d5ejhPTkdxT0RINUxSckllclA0emkwQQ?oc=5","date":"2021-03-04","type":"deal","source":"BioPharma Dive","summary":"Amgen, with rare buyout, pays $1.9B for cancer biotech Five Prime - BioPharma Dive","headline":"Amgen, with rare buyout, pays $1.9B for cancer biotech Five Prime","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxNRnpDR0IxR3k0eVNWUV9rNjA3SG1pM3o5WTZyTi1nVzM3TFNraXJXMlhIaDU1R2FRX2VYemdoZHZSbGI3dEZlMU9SVlk4bWktaFVod0FkNHN1WXZRWENaeklVWjdjVG1TMFlPOUtlWEljalFia205amVYZjA2Z3RKWlBrYWlTM25YYjItYTRiTEFtbUljVXRnQUJFLXRLSnVkblZWY2x3?oc=5","date":"2021-03-04","type":"pipeline","source":"statnews.com","summary":"Amgen spends $1.9 billion on Five Prime, eyeing an expansion in Asia - statnews.com","headline":"Amgen spends $1.9 billion on Five Prime, eyeing an expansion in Asia","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxNYndfR1lzRHdUUXo5Sy0wQ0JOVzdTU25qLWJZVWNVVmhHQ3RqT3hFMFhDVHBwNkFFTkpBVGVfbjFtay1oYjg4bl9DbzQySW5iRFNkMjFDcXB0bzI5bVMteEM1UU9KM2FfS1ZRWmtTSVdQbGVpYS1pRGRjaWM1dWJMWDVuVQ?oc=5","date":"2021-03-04","type":"deal","source":"MassDevice","summary":"Amgen to acquire Five Prime Therapeutics for $1.9B - MassDevice","headline":"Amgen to acquire Five Prime Therapeutics for $1.9B","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxOblptektnei1hYXB2X0J2cW16UFE2dWNXVE5uQWFBZDdlOHBCVVlUNGJjRXhOQlpETktOZk03S2dKb3NoUHZja3F6ZkZLazVwczdrWDE1XzZERnR4NUtMYjVyOUpBX1ZXUVpsT3M2TGljdVJqeVcxc0tfUTc1amtuY1pzc3NZNEpVdzlfNjNUcWt4ZkM0aGdOWnRRbWc0VnlwM0lz?oc=5","date":"2020-11-11","type":"trial","source":"Clinical Trials Arena","summary":"Five Prime Therapeutics reports positive results from Phase II FIGHT trial - Clinical Trials Arena","headline":"Five Prime Therapeutics reports positive results from Phase II FIGHT trial","sentiment":"positive"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"sec_edgar+yahoo","revenue":13178000,"revenuePeriod":"2020-12-31","revenueHistory":[{"value":13178000,"period":"2020-12-31"},{"value":14874000,"period":"2019-12-31"},{"value":49868000,"period":"2018-12-31"},{"value":13218000,"period":"2017-12-31"},{"value":8333000,"period":"2017-09-30"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":65491000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-84328000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":null,"cashHistory":[],"totalAssets":331650000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":null}